Pinaverium Bromide
Basic Information
| Item | Value |
|---|---|
| DrugBank ID | DB09090 |
| Evidence Level | L5 (Computational Prediction) |
| Number of Predicted Indications | 24 |
Predicted Indications (TxGNN)
The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.
| # | Indication | Source |
|---|---|---|
| 1 | benign prostatic hyperplasia (disease) | KG + DL |
| 2 | hypertrichosis (disease) | KG + DL |
| 3 | malformation syndrome with odontal and/or periodontal component | KG + DL |
| 4 | Ambras type hypertrichosis universalis congenita | KG + DL |
| 5 | syndrome with a Dandy-Walker malformation as major feature | KG + DL |
| 6 | isolated genetic hair shaft abnormality | KG + DL |
| 7 | nephrogenic syndrome of inappropriate antidiuresis | KG + DL |
| 8 | prostate calculus | KG + DL |
| 9 | kyphoscoliotic heart disease | KG + DL |
| 10 | pulmonary hypertension | KG + DL |
| 11 | common cold | KG + DL |
| 12 | headache disorder | KG + DL |
| 13 | Prinzmetal angina | KG + DL |
| 14 | trigeminal autonomic cephalalgia | KG + DL |
| 15 | peripheral vascular disease | KG + DL |
| 16 | breast fibrocystic disease | KG + DL |
| 17 | intracranial arteriosclerosis | KG + DL |
| 18 | apocrine adenosis of breast | KG + DL |
| 19 | blunt duct adenosis of breast | KG + DL |
| 20 | intermittent vascular claudication | KG + DL |
| 21 | peripheral arterial disease | KG + DL |
| 22 | mycotic corneal ulcer | KG + DL |
| 23 | nasal cavity disease | KG + DL |
| 24 | anomalous left coronary artery from the pulmonary artery | KG + DL |
Disclaimer
These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.